Evidence map›Paper›PMID 33673432›Full record

ArticleMetabolites2021

Lipidomics Revealed Aberrant Metabolism of Lipids Including FAHFAs in Renal Tissue in the Progression of Lupus Nephritis in a Murine Model.

Changfeng Hu, Yu Du, Xiaofen Xu, Haichang Li, Qiao Duan, Zhijun Xie, Chengping Wen, Xianlin Han

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Changfeng HuCollege of Basic Medical Sciences, Zhejiang Chinese Medical University, 548 Bingwen Road, Hangzhou 310053, China.
Yu DuFirst Clinical Medical College, Zhejiang Chinese Medical University, 548 Bingwen Road, Hangzhou 310053, China.
Xiaofen XuCollege of Basic Medical Sciences, Zhejiang Chinese Medical University, 548 Bingwen Road, Hangzhou 310053, China.
Haichang LiCollege of Basic Medical Sciences, Zhejiang Chinese Medical University, 548 Bingwen Road, Hangzhou 310053, China.
Qiao DuanCollege of Basic Medical Sciences, Zhejiang Chinese Medical University, 548 Bingwen Road, Hangzhou 310053, China.
Zhijun XieCollege of Basic Medical Sciences, Zhejiang Chinese Medical University, 548 Bingwen Road, Hangzhou 310053, China.
Chengping WenCollege of Basic Medical Sciences, Zhejiang Chinese Medical University, 548 Bingwen Road, Hangzhou 310053, China.
Xianlin HanBarshop Institute for Longevity and Aging Studies, San Antonio, TX 78229, USA.ORCID 0000-0002-8615-2413
Zhejiang Chinese Medical University · CNThe University of Texas Health Science Center at San Antonio · US

Funding

TRANSGENIC COREP30AG013319 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI JAMES FLOYD NELSON · 1995 to 2026
$30.6M
National Key R&D Program of China 2018YFC1705501National Natural Science Foundation of China No. 81803861 and 81973829Natural Science Foundation of Zhejiang Province of China No. LY20B050006NIA NIH HHS P30 AG013319
6 · The paper itself

Abstract

Lupus nephritis (LN) is an inflammatory renal disease of patients with systemic lupus erythematosus with lots of immune complexes deposited in kidneys. Accumulated studies have demonstrated the close relationships among dyslipidaemia, inflammation, and autoimmune response, and oxidative stress in the patients. Lipids play numerous important roles in biological process and cellular functions. Herein, shotgun lipidomics was employed to quantitatively analyze cellular lipidomes in the renal tissue of MRL/lpr mice in the progression of LN (including pre-LN and LN state) with/without treated with glucocorticoids (GCs). The levels of cytokines (i.e., TNF-α (Tumor necrosis factor alpha) and IL-6 (Interleukin 6)) in the serum were measured by ELISA (enzyme-linked immunosorbent assay) kits. Renal histopathological changes and C3 deposition in the glomeruli of the mice were also determined. Lipidomics analysis revealed that the ectopic fat deposition and the aberrant metabolism of lipids that were relevant to oxidative stress (e.g., 4-hydroxyalkenal, ceramide, lysophospholipid species, etc.) always existed in the development of LN. Moreover, the anti-inflammatory FAHFA (fatty acid ester of hydroxyl fatty acid) species in the kidney tissue could largely reflect the severity of LN. Thus, they were a potential early biomarker for LN. In addition, the study also revealed that treatment with GCs could prevent the progression of LN, but greatly aggravate the aberrant metabolism of the lipids, particularly when used for a long time.

Indexed as

autoimmune reactionFAHFAslipidomicslupus nephritisoxidative stress

Identifiers

PMID33673432
PMCPMC7996882
OpenAlexW3135868903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.